Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2026

Genmab — Januar 2026

Planlagt Fastgjort Låst Flyttet Genmab
295 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #220

    the whole trial went 'Active, not recruiting' already in june 23 and after the split both had the same Primary Completion date, Oct25, so we may not have to wait that long for the China part. Actually, maybe it is already included, it is a sub-study of DLBCL-1 ?

    1 Reply Last reply
    0
    • P Offline
      P Offline
      Pensionisten
      wrote on sidst redigeret af
      #221

      Føj......(-:

      1 Reply Last reply
      0
      • W Offline
        W Offline
        w
        wrote on sidst redigeret af
        #222

        genmab classic

        1 Reply Last reply
        0
        • V Offline
          V Offline
          Vitus
          wrote on sidst redigeret af
          #223

          Massakren er en realitet

          1 Reply Last reply
          0
          • G Offline
            G Offline
            gentogen
            wrote on sidst redigeret af
            #224

            The number of patients in the recent data shows that China is not included so far

            1 Reply Last reply
            0
            • P Offline
              P Offline
              Pensionisten
              wrote on sidst redigeret af
              #225

              Der blev lidt tavst på chatten ! Er det Over and out, and RIP?

              1 Reply Last reply
              0
              • concilladoC Offline
                concilladoC Offline
                concillado
                wrote on sidst redigeret af
                #226

                Man skulle da lige have taget lidt gevinsthjemtagning i 2250 😉

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  gdn55
                  wrote on sidst redigeret af
                  #227

                  Hvorfor det

                  1 Reply Last reply
                  0
                  • concilladoC Offline
                    concilladoC Offline
                    concillado
                    wrote on sidst redigeret af
                    #228

                    ...inden Trump-babyen gik i gang igen. "Kun" 3 år tilbage med hans rablende infantile vanvid xD

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #229

                      ok gentogen , than we have something to look forward to

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #230

                        DNB Carnegie løfter Genmabs anbefaling til "køb" og skruer pænt op for kursmålet https://proinvestor.com/investornyt/1405261/dnb-carnegie-lofter-genmabs-anbefaling-til-kob-og-skruer-paent-op-for-kursmalet

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #231

                          hey gentogen , thinking again on that China part of the trial ; too many Asian patients in the trial was where Roche/Genentech got in trouble with Columvi wasn't it; they got a Complete Response Letter from the FDA for the reason that OS was much better in Asian patients compared to non-Asian patients so FDA determined OS was not proven for Americans

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #232

                            and that was Columvi chemo combination and they
                            still have the accelerated approval

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #233
                              • 4Q DARZALEX REVENUE $3.90B, EST. $3.75B
                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #234

                                https://ir.genmab.com/news-releases/news-release-details/genmab-announces-net-sales-darzalexr-daratumumab-2025

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #235

                                  Far above top end of prognosis interval.

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    Peter_Panik
                                    wrote on sidst redigeret af
                                    #236

                                    Genmabs amerikanske partner Johnson & Johnson overgår analytikernes forventninger med sine salgstal for kræftmidlet Darzalex i fjerde kvartal.

                                    Salget af Darzalex løber op i 3903 mio. dollar i perioden, mens analytikere havde ventet 3748 mio. dollar ifølge Bloomberg News.

                                    I forhold til samme kvartal sidste år er Darzalex-salget steget 24 pct. i lokal valuta.

                                    For hele 2025 endte Johnson & Johnsons salg af Darzalex, som Genmab får procenter af, på 14.351 mio. dollar.

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      Peter_Panik
                                      wrote on sidst redigeret af
                                      #237

                                      Det viser onsdagens regnskab fra Johnson & Johnson.

                                      Darzalex-salget lander dermed over Genmabs prognose for 2025 om et salg på 13,7 til 14,1 mia. dollar.

                                      Genmab estimerede i sit seneste regnskab, at det vil modtage royalties fra salget af Darzalex på 2,3-2,4 mia. dollar i 2025.

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        Peter_Panik
                                        wrote on sidst redigeret af
                                        #238

                                        Isoleret set et stærkt resultat

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #239

                                          RYBREVANT / LAZCLUZE Q4 2025 US 146 Intl 70 WW 216 (Q3 2025 US 136 Intl 61 WW 198) (total 2025 734 vs 327 2024)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper